1
|
Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, Lettera E, Deyell M, Tavora B, Havel JJ, Phyu SM, Amin AD, Budre K, Kamiya E, Cavallo JA, Garris C, Powell S, Reis-Filho JS, Wen H, Bettigole S, Khan AJ, Izar B, Parkes EE, Laughney AM, Bakhoum SF. Non-cell-autonomous cancer progression from chromosomal instability. Nature 2023; 620:1080-1088. [PMID: 37612508 PMCID: PMC10468402 DOI: 10.1038/s41586-023-06464-z] [Citation(s) in RCA: 33] [Impact Index Per Article: 33.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 07/20/2023] [Indexed: 08/25/2023]
Abstract
Chromosomal instability (CIN) is a driver of cancer metastasis1-4, yet the extent to which this effect depends on the immune system remains unknown. Using ContactTracing-a newly developed, validated and benchmarked tool to infer the nature and conditional dependence of cell-cell interactions from single-cell transcriptomic data-we show that CIN-induced chronic activation of the cGAS-STING pathway promotes downstream signal re-wiring in cancer cells, leading to a pro-metastatic tumour microenvironment. This re-wiring is manifested by type I interferon tachyphylaxis selectively downstream of STING and a corresponding increase in cancer cell-derived endoplasmic reticulum (ER) stress response. Reversal of CIN, depletion of cancer cell STING or inhibition of ER stress response signalling abrogates CIN-dependent effects on the tumour microenvironment and suppresses metastasis in immune competent, but not severely immune compromised, settings. Treatment with STING inhibitors reduces CIN-driven metastasis in melanoma, breast and colorectal cancers in a manner dependent on tumour cell-intrinsic STING. Finally, we show that CIN and pervasive cGAS activation in micronuclei are associated with ER stress signalling, immune suppression and metastasis in human triple-negative breast cancer, highlighting a viable strategy to identify and therapeutically intervene in tumours spurred by CIN-induced inflammation.
Collapse
Affiliation(s)
- Jun Li
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Melissa J Hubisz
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
- Bioinformatics Facility, Institute of Biotechnology, Cornell University, Ithaca, NY, USA
| | - Ethan M Earlie
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
| | - Mercedes A Duran
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Christy Hong
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Austin A Varela
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
| | - Emanuele Lettera
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Matthew Deyell
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
| | | | | | - Su M Phyu
- Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK
| | - Amit Dipak Amin
- Columbia Center for Translational Immunology, New York, NY, USA
- Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA
| | - Karolina Budre
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
| | - Erina Kamiya
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
| | - Julie-Ann Cavallo
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Christopher Garris
- Department of Pathology, Harvard Medical School, Boston, MA, USA
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA
| | - Simon Powell
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jorge S Reis-Filho
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Hannah Wen
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | - Atif J Khan
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Benjamin Izar
- Columbia Center for Translational Immunology, New York, NY, USA
- Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA
| | - Eileen E Parkes
- Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK
| | - Ashley M Laughney
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
- Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
- Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
| | - Samuel F Bakhoum
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
| |
Collapse
|
2
|
Deyell M, Bakhoum SF. Unjamming tumour cell invasion through cGAS-STING. Nat Mater 2023; 22:532-533. [PMID: 37138010 DOI: 10.1038/s41563-023-01542-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Affiliation(s)
- Matthew Deyell
- Department of Physiology and Biophysics and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
| | - Samuel F Bakhoum
- Human Oncology and Pathogenesis Program and Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
| |
Collapse
|
3
|
Naderi B, Krahn A, Roston T, Khan H, Sanatani S, Laksman Z, Deyell M, Davies B. DIAGNOSTIC UTILITY OF HOLTER MONITORING IN CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA. Can J Cardiol 2022. [DOI: 10.1016/j.cjca.2022.08.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
4
|
Li J, Hubisz M, Earlie E, Duran MA, Lettera E, Phyu SM, Amin AD, Deyell M, Kamiya E, Budre K, Cavallo JA, Garris C, Wen H, Izar B, Parkes E, Laughney A, Bakhoum S. Abstract 3822: Chromosomal instability shapes the tumor microenvironment through a chronic ER-stress response. Cancer Res 2022. [DOI: 10.1158/1538-7445.am2022-3822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Chromosomal instability (CIN) is a cancer hallmark associated with cancer metastasis and immune evasion. Yet, it is unclear how CIN modulates the tumor-microenvironment (TME). Here we show that CIN results in a protumor TME with enrichment of immune-suppressive macrophages, a granulocytic infiltrate, and exhausted T cells. Using ContactTracing, a newly developed computational tool to infer conditionally dependent cell-cell interactions from single cell RNA sequence data, we identify tumor ligands induced by the ER stress response in cancer cells as central mediators of immune suppression. Mechanistically, CIN-dependent chronic activation of the cytosolic DNA sensing cGAS-STING pathway promotes ER-stress-dependent transcription. Suppression of CIN or depletion of cancer cell STING reduces ER-stress and restores CIN-induced changes on the TME. Correspondingly, chronic STING activation in human breast cancer patients is associated with reduced tumor infiltrating lymphocytes and increased metastasis. Remarkably, pharmacologic inhibition of chronically active STING or depletion of downstream ER stress signaling suppresses metastasis in syngeneic models of melanoma, breast, and colorectal cancers, thereby demonstrating a viable therapeutic strategy for chromosomally unstable cancers.
Citation Format: Jun Li, Melissa Hubisz, Ethan Earlie, Mercedes A. Duran, Emanuele Lettera, Su M. Phyu, Amit D. Amin, Matthew Deyell, Erina Kamiya, Karolina Budre, Julie-Ann Cavallo, Christopher Garris, Hannah Wen, Benjamin Izar, Eileen Parkes, Ashley Laughney, Samuel Bakhoum. Chromosomal instability shapes the tumor microenvironment through a chronic ER-stress response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3822.
Collapse
Affiliation(s)
- Jun Li
- 1Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | | | | | | - Su M. Phyu
- 3University of Oxford, Oxford, United Kingdom
| | - Amit D. Amin
- 4Columbia University Medical Center, New York, NY
| | | | | | | | | | | | - Hannah Wen
- 1Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | | | | | |
Collapse
|
5
|
Laksman Z, Singer E, Fraser S, Semsarian C, Deyell M, Bagnall R. Epicardial Ablation of Recurrent Ventricular Fibrillation in the Context of a Novel SCN5A Intronic Splice Variant. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
6
|
Hosseini F, Gulsin G, Murphy D, Hawkins N, Andrade J, Laksman Z, Bennett M, Yeung-Lai-Wah J, Chakrabarti S, Krahn A, Deyell M. Magnetic resonance imaging in the evaluation of idiopathic frequent premature ventricular complexes with normal ventricular function. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
The role of cardiac magnetic resonance (CMR) imaging in the diagnostic evaluation of patients with frequent premature ventricular complexes (PVCs) and normal left ventricular ejection fraction (LVEF) remains unclear. Existing data has been predominantly derived from highly selected populations, that may overestimate the true prevalence of abnormal findings on CMR in this patient population.
Purpose
The aim of this study was 2-fold: 1) to establish the prevalence of CMR imaging abnormalities in a cohort with normal LVEF and high PVC burden; 2) to identify predictors of CMR imaging abnormalities in patients with frequent PVCs and normal LVEF.
Methods
In this cohort study, 211 patients (age 53.2±19 years; 41% male) with frequent PVCs (≥5%/24 h), of normal LVEF (≥50% by echocardiography) and no known underlying structural heart disease were prospectively enrolled from 2016–2020. Of these, 166 (79%) patients were symptomatic from their PVCs in the form of palpitations, fatigue, chest pain, dizziness, and/or dyspnea. Patients underwent CMR imaging (1.5 Tesla) with a late gadolinium enhancement (LGE) protocol at the time of enrollment for the detection of scarring and/or fibrosis.
Results
Patients had a median baseline echocardiographic LVEF of 60% (± 5%) with 195 (92%) of patients having a normal native QRS morphology. Median PVC burden of the study cohort was 16% (± 14%). CMR LGE abnormalities were found in 19 (9%) patients including 17 scans with non-ischemic LGE and 2 with ischemic LGE. Age >60 (odds ratio [OR]: 3.20, 95% confidence interval [CI]: 1.20–8.51, p=0.020), male sex (OR: 4.67, 95% CI: 1.61–13.50, p=0.004), history of hypertension (OR: 3.43, 95% CI: 1.31–8.97, p=0.012), native QRS duration (OR: 1.03, 95% CI: 1.00–1.05, p=0.031), and history of non-sustained ventricular tachycardia (OR: 2.81, 95% CI: 1.03–7.68, p=0.044) were significantly associated with the presence of imaging abnormalities on CMR. Dominant PVC origin from the left ventricle had a positive trend (OR: 2.60, 95% CI: 0.99–7.66, p=0.083) to association with CMR imaging abnormalities. On multivariate analysis, male sex (OR: 4.10, 95% CI: 1.40–12.04, p=0.010) and history of hypertension (OR: 2.89, 95% CI: 1.08–7.75, p=0.035) remained significantly associated with the presence of CMR abnormalities. There was no association between CMR imaging abnormalities and the burden of PVCs or the number of PVC morphologies.
Conclusion
In this cohort, only 9% of patients with apparently idiopathic frequent PVCs and normal LVEF had concealed myocardial abnormalities on CMR imaging. Male sex and history of hypertension were associated with a higher rate of CMR abnormalities.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- F Hosseini
- University of British Columbia, Division of Internal Medicine, Department of Medicine, Vancouver, Canada
| | - G Gulsin
- University of British Columbia, Department of Radiology, Vancouver, Canada
| | - D Murphy
- University of British Columbia, Department of Radiology, Vancouver, Canada
| | - N Hawkins
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| | - J Andrade
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| | - Z Laksman
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| | - M Bennett
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| | - J Yeung-Lai-Wah
- University of British Columbia, Heart Rhythm Services, Vancouver, Canada
| | - S Chakrabarti
- University of British Columbia, Heart Rhythm Services, Vancouver, Canada
| | - A Krahn
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| | - M Deyell
- University of British Columbia, Heart Rhythm Services, Centre for Cardiovascular Innovation, Vancouver, Canada
| |
Collapse
|
7
|
Salmasi S, Safari A, De Vera M, Lynd L, Koehoorn M, Bary A, Andrade J, Deyell M, Rush K, Zhao Y, Loewen P. Comparative adherence between DOAC and VKA in patients with atrial fibrillation: a 23-year retrospective observational study in Canada. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
A recent systematic review highlighted significant gaps in the evidence on atrial fibrillation (AF) patients' adherence to oral anticoagulants (OAC). Current evidence suffers from short follow-up times, focuses on the first OAC and does not take switching into account. There is also lack of observational data on adherence to warfarin due to its varying dose that complicates the calculations. As such there is lack of evidence on comparative adherence between VKAs and DOACs and whether the convenience of DOACs translates into better adherence in AF patients.
Purpose
Our objective was to measure AF patients' long-term OAC adherence and compare the impact of taking direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) on adherence, while accounting for switching.
Methods
Using linked, population-based administrative data containing physician billings, hospitalization and prescription records of 4.8 million British Columbians (1996–2019), incident adult cases of AF were identified. The primary measure of adherence was proportion of days covered (PDC). Consecutive rolling 90-day windows were created for each patient starting from their first OAC prescription fill date until the end of their follow-up. The PDC for each 90-day rolling window was calculated and averaged to yield mean adherence over the follow-up period for each patient. Permanent medication discontinuation resulted in a PDC of 0 for all subsequent rolling windows after their supply ran out. As such, both poor execution and non-persistence were measured simultaneously. The association between drug class and adherence was assessed using generalized mixed effect linear regression models with drug class treated as time-varying covariate to account for switching.
Results
The study cohort was 30,264 AF patients [mean age 72.2 years (SD11.0), 44.6% female, mean CHA2DS2-VASc 2.94 (SD1.4)] with mean follow-up of 7.7 (SD 4.8) years. The mean PDC was 0.71 (SD 0.27) with 51% of the cohort having mean PDC values below the conventional threshold of adherence (PDC<0.8). Adherence dropped over time with the greatest decline in the first two years after therapy initiation. After controlling for all other confounders and accounting for switching, taking VKA compared to DOAC was, on average, associated with a 1-day decrease in number of days of medication-taking per year.
Conclusion
AF patients' OAC adherence was below the conventional threshold of 0.8, and dropped over time, particularly in the first two years. Drug class had no clinically meaningful impact on medication adherence. Our study highlights the need for effective adherence interventions particularly early in OAC therapy. Our findings also emphasizes that prescribers should not assume inherently better adherence for DOACs and should instead choose OAC in conversation with the patient and in accordance with their values and preferences.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Canadian Institutes of Health Research grant
Collapse
Affiliation(s)
- S Salmasi
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| | - A Safari
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| | - M.A De Vera
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| | - L Lynd
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| | - M Koehoorn
- University of British Columbia, School of Population and Public Health, Vancouver, Canada
| | - A.R Bary
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| | - J.G Andrade
- University of British Columbia, Faculty of Medicine, Vancouver, Canada
| | - M Deyell
- University of British Columbia, Faculty of Medicine, Vancouver, Canada
| | - K Rush
- University of British Columbia, Faculty of applied sciences, Vancouver, Canada
| | - Y Zhao
- University of British Columbia, Faculty of Medicine, Vancouver, Canada
| | - P Loewen
- University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, Canada
| |
Collapse
|
8
|
Salmasi S, Safari A, De Vera M, Lynd L, Koehoorn M, Barry A, Andrade J, Deyell M, Rush K, Zhao Y, Loewen P. LONGITUDINAL ORAL ANTICOAGULANT ADHERENCE PATTERNS IN PATIENTS WITH ATRIAL FIBRILLATION: A RETROSPECTIVE OBSERVATIONAL STUDY. Can J Cardiol 2021. [DOI: 10.1016/j.cjca.2021.07.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
9
|
Hosseini F, Gulsin G, Murphy D, Hawkins N, Andrade J, Laksman Z, Bennett M, Yeung-Lai-Wah J, Chakrabarti S, Krahn A, Deyell M. MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF IDIOPATHIC FREQUENT PREMATURE VENTRICULAR COMPLEXES. Can J Cardiol 2021. [DOI: 10.1016/j.cjca.2021.07.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
10
|
Abstract
Most cancer deaths are caused by metastasis: recurrence of disease by disseminated tumour cells at sites distant from the primary tumour. Large numbers of disseminated tumour cells are released from the primary tumour, even during the early stages of tumour growth. However, only a minority survive as potential seeds for future metastatic outgrowths. These cells must adapt to a relatively inhospitable microenvironment, evade immune surveillance and progress from the micro- to macro-metastatic stage to generate a secondary tumour. A pervasive driver of this transition is chronic inflammatory signalling emanating from tumour cells themselves. These signals can promote migration and engagement of stem and progenitor cell function, events that are also central to a wound healing response. In this review, we revisit the concept of cancer as a non-healing wound, first introduced by Virchow in the 19th century, with a new tumour cell-intrinsic perspective on inflammation and focus on metastasis. Cellular responses to inflammation in both wound healing and metastasis are tightly regulated by crosstalk with the surrounding microenvironment. Targeting or restoring canonical responses to inflammation could represent a novel strategy to prevent the lethal spread of cancer.
Collapse
Affiliation(s)
- Matthew Deyell
- grid.5386.8000000041936877XInstitute for Computational Biomedicine, Weill Cornell Medicine, New York, NY USA ,grid.5386.8000000041936877XDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY USA ,grid.5386.8000000041936877XSandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY USA ,grid.4444.00000 0001 2112 9282Chimie Biologie et Innovation, ESPCI Paris, Université PSL, CNRS, Paris, France
| | | | - Ashley M. Laughney
- grid.5386.8000000041936877XInstitute for Computational Biomedicine, Weill Cornell Medicine, New York, NY USA ,grid.5386.8000000041936877XDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY USA ,grid.5386.8000000041936877XSandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY USA
| |
Collapse
|
11
|
Steinberg C, Cheung C, Wan D, Staples J, Philippon F, Laksman Z, Sarrazin J, Bennett M, Plourde B, Deyell M, Andrade J, Roy K, Yeung-Lai-Wah J, Molin F, Hawkins N, Blier L, Nault I, O'Hara G, Krahn A, Champagne J, Chakrabarti S. DRIVING RESTRICTIONS AND EARLY ARRHYTHMIAS IN PATIENTS RECEIVING A PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (DREAM-ICD STUDY). Can J Cardiol 2019. [DOI: 10.1016/j.cjca.2019.07.570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
12
|
Cheung C, Bashir J, Laksman Z, Deyell M, Nouraei H, Yeung J, Bennett M, Andrade J, Krahn A, Chakrabarti S. CHANGES IN ELECTROGRAM AMPLITUDE AND INAPPROPRIATE SHOCKS IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS. Can J Cardiol 2019. [DOI: 10.1016/j.cjca.2019.07.407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
13
|
Deyell M, Ameta S, Nghe P. Large scale control and programming of gene expression using CRISPR. Semin Cell Dev Biol 2019; 96:124-132. [PMID: 31181342 DOI: 10.1016/j.semcdb.2019.05.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Accepted: 05/14/2019] [Indexed: 12/22/2022]
Abstract
The control of gene expression in cells and organisms allows to unveil gene to function relationships and to reprogram biological responses. Several systems, such as Zinc fingers, TALE (Transcription activator-like effectors), and siRNAs (small-interfering RNAs), have been exploited to achieve this. However, recent advances in Clustered Regularly Interspaced Short Palindromic Repeats and Cas9 (CRISPR-Cas9) have overshadowed them due to high specificity, compatibility with many different organisms, and design flexibility. In this review we summarize state-of-the art for CRISPR-Cas9 technology for large scale gene perturbation studies, including single gene and multiple genes knock-out, knock-down, knock-up libraries, and their associated screening assays. We feature in particular the combination of these methods with single-cell transcriptomics approaches. Finally, we highlight the application of CRISPR-Cas9 systems in building synthetic circuits that can be interfaced with gene networks to control cellular states.
Collapse
Affiliation(s)
- Matthew Deyell
- Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France
| | - Sandeep Ameta
- Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France
| | - Philippe Nghe
- Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France.
| |
Collapse
|
14
|
Forman J, Gwozd T, Deyell M. IMPROVING PATIENTS' EXPERIENCE OF SAME-DAY DISCHARGE AFTER ATRIAL FIBRILLATION ABLATION. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
15
|
Cheung C, Deyell M, Laksman Z, Yeung J, Andrade J, Bennett M, Hawkins N, Krahn A, Chakrabarti S. ATRIAL ARRHYTHMIAS AND INAPPROPRIATE DEFIBRILLATOR THERAPY: YOU HAVE BEEN WARNED! Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
16
|
Malhi N, Moghaddam N, Andrade J, Hawkins N, Krahn A, Deyell M. CATHETER ABLATION OF ATRIAL FIBRILLATION IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.340] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
17
|
Yao R, Hawkins N, Deyell M, Cheung C, Fordyce C, Wong G, Macle L, Andrade J. ANTITHROMBOTIC THERAPIES FOR PATIENTS WITH AN INDICATION FOR ANTICOAGULATION AND STABLE CORONARY ARTERY DISEASE: A NETWORK META-ANALYSIS. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
18
|
Yao R, MacGillivray J, Macle L, Bennett M, Hawkins N, Krahn A, Jue J, Colley P, Manhas K, Ramanathan K, Fordyce C, Tsang T, Gin K, Deyell M, Andrade J. REAL-WORLD SAFETY AND EFFICACY OF A ‘PILL-IN-THE-POCKET' APPROACH FOR THE MANAGEMENT OF PAROXYSMAL ATRIAL FIBRILLATION. Can J Cardiol 2017. [DOI: 10.1016/j.cjca.2017.07.371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
19
|
Gula L, Leong-Sit P, Tang A, Parkash R, Sarrazin J, Thibault B, Essebag V, Deyell M, Lane C, Nery P, Veenhuyzen G, Redfearn D, Healey J, Roux J, Doucette S, Sapp J. QUALITY OF LIFE IN PATIENTS WITH ABLATION OR MEDICAL THERAPY FOR VENTRICULAR ARRHYTHMIAS: A SUBSTUDY OF VANISH. Can J Cardiol 2017. [DOI: 10.1016/j.cjca.2017.07.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
20
|
Nazzari H, Ramanathan K, Wong G, Taylor C, Deyell M, Grewal J, Tang J, Largy W, Perry-Arnesen M, Toma M. MINERALOCORTICOID RECEPTOR ANTAGONIST UTILIZATION IN ELIGIBLE PATIENTS POST ST-ELEVATION MYOCARDIAL INFARCTION. Can J Cardiol 2015. [DOI: 10.1016/j.cjca.2015.07.410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
21
|
MacGillivray J, Bennett M, Colley P, Deyell M, Gin K, Krahn A, Jue J, Manhas K, Ramanathan K, Tsang T, Andrade J. VARIABILITY IN ANTICOAGULATION DOSE ADJUSTMENT BASED ON DIFFERENT RENAL FUNCTION ESTIMATION FORMULAE. Can J Cardiol 2015. [DOI: 10.1016/j.cjca.2015.07.184] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
22
|
Libis VK, Bernheim AG, Basier C, Jaramillo-Riveri S, Deyell M, Aghoghogbe I, Atanaskovic I, Bencherif AC, Benony M, Koutsoubelis N, Löchner AC, Marinkovic ZS, Zahra S, Zegman Y, Lindner AB, Wintermute EH. Silencing of antibiotic resistance in E. coli with engineered phage bearing small regulatory RNAs. ACS Synth Biol 2014; 3:1003-6. [PMID: 25524110 DOI: 10.1021/sb500033d] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
In response to emergent antibiotic resistance, new strategies are needed to enhance the effectiveness of existing antibiotics. Here, we describe a phagemid-delivered, RNA-mediated system capable of directly knocking down antibiotic resistance phenotypes. Small regulatory RNAs (sRNAs) were designed to specifically inhibit translation of chloramphenicol acetyltransferase and kanamycin phosphotransferase. Nonlytic phagemids coding for sRNA expression were able to infect and restore chloramphenicol and kanamycin sensitivity to populations of otherwise resistant E. coli. This modular system could easily be extended to other bacteria with resistance profiles that depend on specific transcripts.
Collapse
Affiliation(s)
| | | | - Clovis Basier
- 2013 Paris Bettencourt iGEM team, 75014 Paris, France
| | | | | | | | | | | | | | | | | | | | - Sarah Zahra
- 2013 Paris Bettencourt iGEM team, 75014 Paris, France
| | | | - Ariel B. Lindner
- 2013 Paris Bettencourt iGEM team, 75014 Paris, France
- U1001 Institut National de la Santé et de la Recherche Médicale, 75654 Paris, France
| | - Edwin H. Wintermute
- 2013 Paris Bettencourt iGEM team, 75014 Paris, France
- U1001 Institut National de la Santé et de la Recherche Médicale, 75654 Paris, France
| |
Collapse
|
23
|
Atanaskovic I, Bencherif AC, Deyell M, Jaramillo-Riveri S, Benony M, Bernheim AG, Libis VK, Koutsoubelis N, Zegman Y, Löchner AC, Basier C, Aghoghogbe I, Marinkovic ZS, Zahra S, Toulouze M, Lindner AB, Wintermute EH. In situ characterization of mycobacterial growth inhibition by lytic enzymes expressed in vectorized E. coli. ACS Synth Biol 2014; 3:932-4. [PMID: 25408994 DOI: 10.1021/sb500039z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The emergence of extremely drug resistant Mycobacterium tuberculosis necessitates new strategies to combat the pathogen. Engineered bacteria may serve as vectors to deliver proteins to human cells, including mycobacteria-infected macrophages. In this work, we target Mycobacterium smegmatis, a nonpathogenic tuberculosis model, with E. coli modified to express trehalose dimycolate hydrolase (TDMH), a membrane-lysing serine esterase. We show that TDMH-expressing E. coli are capable of lysing mycobacteria in vitro and at low pH. Vectorized E. coli producing TDMH were found suppress the proliferation of mycobacteria in infected macrophages.
Collapse
Affiliation(s)
- Iva Atanaskovic
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Amel Camélia Bencherif
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Matthew Deyell
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Sebastián Jaramillo-Riveri
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Marguerite Benony
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Aude G. Bernheim
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Vincent K. Libis
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Nicolas Koutsoubelis
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Yonatan Zegman
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Anne C. Löchner
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Clovis Basier
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Idonnya Aghoghogbe
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Zoran S. Marinkovic
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Sarah Zahra
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Matthias Toulouze
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
| | - Ariel B. Lindner
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
- U1001 Institut
National de la Santé et de la Recherche Médicale, 75014 Paris, France
| | - Edwin H. Wintermute
- 2013
Paris Bettencourt iGEM team, Centre for Research and Interdisciplinarity, Paris Descartes University, 75014 Paris, France
- U1001 Institut
National de la Santé et de la Recherche Médicale, 75014 Paris, France
| |
Collapse
|
24
|
Tung S, Yee R, Deyell M, Rajagopalan K, Thompson C, Krahn A, Tang A, Moss R. SUPERIOR APPROACH IMPLANTATION OF ENDOCARDIAL LV LEAD IS EFFECTIVE IN PROVIDING CARDIAC RESYNCHRONIZATION THERAPY. Can J Cardiol 2014. [DOI: 10.1016/j.cjca.2014.07.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
25
|
Padfield G, Swampillai J, Steinberg C, Dosan C, Yeung-Lai-Wah J, Tung S, Bennett M, Krahn A, Andrade J, Deyell M. MEXILETINE USE FOR VENTRICULAR TACHYCARDIA REFRACTORY TO STANDARD ANTIARRHYTHMIC THERAPY IN THE ICD ERA. Can J Cardiol 2014. [DOI: 10.1016/j.cjca.2014.07.528] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
26
|
Andrade JG, Pollak SJ, Monir G, Khairy P, Dubuc M, Roy D, Talajic M, Deyell M, Bennett M, Dyrda K, Rivard L, Thibault B, Guerra PG, Nattel S, Macle L. Pulmonary Vein Isolation Using a “Pace-Capture Guided” Versus an “Adenosine Guided” Approach: the Effect on Dormant Conduction and Long-Term Freedom From Recurrent Af: A Prospective Study. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
27
|
Bhole V, Man J, Deyell M, Kiess M, Kerr C, Yeung-Lai-Wah J, Chakrabarti S. 175 Cavotricuspid isthmus dependent atrial flutter in adults with congenital heart disease - single centre experience over a decade. Can J Cardiol 2011. [DOI: 10.1016/j.cjca.2011.07.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|